Company profile

OBS MEDICAL

Population Health & Healthcare Analytics

Company profile

About OBS MEDICAL

OBS Medical is a UK-based health technology company that manufactures and distributes clinical decision support software (CDSS) designed to help healthcare professionals manage and monitor complex health conditions more effectively. The company's flagship product, Visensia, is an interoperability and analytics platform that combines clinical data from legacy patient monitoring infrastructure with the latest wearable and sensor technology, displaying it via a single intuitive clinical dashboard. The Visensia Safety Index uses artificial intelligence and predictive analytics to provide early recognition and response to clinical deterioration in hospital patients, helping to prioritise clinical workflow, empower point-of-care teams, and predict and prevent critical crises. OBS Medical serves hospitals, emergency medical services, home monitoring/virtual wards, and remote patient monitoring applications. The company partners with leading healthcare organisations, hospital data service providers, and medical device manufacturers including Baxter-Hillrom, Therapeutic Monitoring Systems, QRS, and Qardio. Their technology has received regulatory clearances including Health Canada authorisation and FDA clearance through partner integrations. OBS Medical's mission is to deliver clinical information that saves lives and improves workflow through simplification, risk identification, and prevention.

Company description OBS MEDICAL official website

Primary marketPopulation Health & Healthcare Analytics
Commercial modelCommercial information available on request
Company presenceX
Work at OBS MEDICAL?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Clinical deterioration
  • Critical care monitoring
  • Extubation failure risk
  • Mechanically ventilated patients
  • Patient instability

Who it serves

  • Ambulance services
  • Emergency Medical Services
  • Healthcare institutions
  • Home monitoring/Virtual Wards
  • Hospitals
  • Private clinics

Deployment & integration

Cloud Saas · Hybrid · On Premise deployment with recorded integration context.

Recorded integration context: Baxter-Hillrom WAVE Clinical Platform, Excel Medical Electronics, Legacy patient monitoring systems, Qardio wearables, QRS medical equipment, Therapeutic Monitoring Systems.

Geographic context

MarketsCanada · European Economic Area (EEA) · Japan · UK · USA (through partners)
Company sourceOfficial website

Company milestones

Platform expansion

Health Canada authorisation for Visensia (April 2024), Partnership with Nihon Kohden for Japan market (March 2021), Partnership with Therapeutic Monitoring Systems for Extubation Advisor (June 2021), QardioMD+VSI remote monitoring solution launch (May 2020)

Partnerships

Recorded partners

  • Baxter-Hillrom (Welch Allyn)
  • CareTaker Medical
  • Connexall
  • Excel Medical Electronics
  • Nihon Kohden (Japan market)
  • Qardio
  • QRS
  • Therapeutic Monitoring Systems (TMS)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Extubation Advisor (EA)

AI-driven decision support for predicting extubation outcomes in ICU patients

Software · On PremiseCompany source

QardioMD+VSI

Remote monitoring combining Qardio wearables with Visensia predictive algorithms

Platform · Cloud SaaSCompany source

Visensia

AI-powered clinical decision support for early detection of patient deterioration

Software · HybridCompany source

Visensia for Home

Remote patient monitoring solution for virtual wards and home care

Software · Cloud SaaSCompany source

Visensia for Hospitals

Inpatient monitoring solution for early detection of clinical deterioration

Software · On PremiseCompany source

Visensia Mobile

Mobile clinical decision support for emergency medical services

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

One third fewer transfers to intensive care

Hospital research with continuous monitoring

Early recognition and response to clinical deterioration

In-hospital patients

Improved extubation outcomes

ICU mechanically ventilated patients

Unnamed Hospital (Netherlands)

Continuous monitoring to reduce ICU transfers

One third fewer transfers to intensive care

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from OBS MEDICAL

Recent articles published on OBS MEDICAL's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Population Health & Healthcare Analytics

Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon